| Overview |
| bsm-90043r-50µL |
| PAK2 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human PAK2 |
| 1-39/524 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 5062 |
| Q13177 |
| PAK2; P21 (RAC1) Activated Kinase 2; PAK65; S6/H4 Kinase; P21 Protein (Cdc42/Rac)-Activated Kinase 2; Serine/Threonine-Protein Kinase PAK 2; P21 (CDKN1A)-Activated Kinase 2; P21-Activated Kinase 2; EC 2.7.11.1; Gamma-PAK; PAKgamma; PAK-2; P58; EC 2.7.11; PAKGAMMA; KNO2 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz